Pfizer’s $13.5 Billion Debt Offering

On March 24, 2009, Pfizer Inc. announced the completion of its $13.5 billion registered debt offering. The offering consisted of five tranches of debt with maturities ranging from two to 30 years. Cravath represented the underwriters, led by Banc of America Securities LLC, Barclays Capital Inc., Citigroup Global Markets Inc., Goldman, Sachs & Co. and JPMorgan, in connection with this transaction. The lawyers involved include partner Andrew J. Pitts, senior attorney G. Douglas Johnson and associates Damayanti J. Shahani and Adam D. Rosenthal.